Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
Mary P. Udumula et al.
CANCERS (2022)
The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP
Wei Yue et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
Concetta Altamura et al.
CANCERS (2021)
A crowdsourcing open platform for literature curation in UniProt
Yuqi Wang et al.
PLOS BIOLOGY (2021)
Lipid metabolism and Calcium signaling in epithelial ovarian cancer
Sana Kouba et al.
CELL CALCIUM (2019)
Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
Chen Yang et al.
ONCOLOGY LETTERS (2019)
Ovarian cancer: Current status and strategies for improving therapeutic outcomes
Ashwin Chandra et al.
CANCER MEDICINE (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Editorial: Metformin: Beyond Diabetes
Frederic Bost et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Estrogen Receptors alpha and beta in Ovarian Cancer: Expression Level and Prognosis
T. A. Bogush et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2018)
Role of metformin in inhibiting estrogen-induced proliferation and regulating ER alpha and ER beta expression in human endometrial cancer cells
Jingbo Zhang et al.
ONCOLOGY LETTERS (2017)
BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
Zhongyang Liu et al.
SCIENTIFIC REPORTS (2016)
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
Ernst Lengyel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
The MAPK Pathway Across Different Malignancies: A New Perspective
Mauricio Burotto et al.
CANCER (2014)
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
David Gfeller et al.
NUCLEIC ACIDS RESEARCH (2014)
Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
Tae Hun Kim et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Metformin intake is associated with better survival in ovarian cancer A Case-Control Study
Sanjeev Kumar et al.
CANCER (2013)
The Effects of Metformin on Ovarian Cancer A Systematic Review
Piyemeth Dilokthornsakul et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Inflammation and ovarian cancer
Antonio Maccio et al.
CYTOKINE (2012)
Metformin targets ovarian cancer stem cells in vitro and in vivo
Jessica J. Shank et al.
GYNECOLOGIC ONCOLOGY (2012)
Breast and Ovarian Cancers: A Survey and Possible Roles for the Cell Surface Heparan Sulfate Proteoglycans
Atsuko Yoneda et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
Iris L. Romero et al.
OBSTETRICS AND GYNECOLOGY (2012)
Metformin inhibits the development and metastasis of ovarian cancer
Buchu Wu et al.
ONCOLOGY REPORTS (2012)
Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins
Amber Yasmeen et al.
GYNECOLOGIC ONCOLOGY (2011)
Use of metformin and the risk of ovarian cancer: A case-control analysis
Michael Bodmer et al.
GYNECOLOGIC ONCOLOGY (2011)
Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
Michael P. Stany et al.
PLOS ONE (2011)
Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
Ramandeep Rattan et al.
NEOPLASIA (2011)
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach
Xiaofeng Liu et al.
NUCLEIC ACIDS RESEARCH (2010)
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok et al.
CANCER CELL (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Estrogen receptor subtypes in ovarian cancer - A clinical correlation
Karen K. L. Chan et al.
OBSTETRICS AND GYNECOLOGY (2008)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)